Genetic Technologies

$4.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-0.91%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GENE and other stocks, options, and ETFs commission-free!

About GENE

Genetic Technologies Ltd Sponsored ADR, also called Genetic Technologies, is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia. The listed name for GENE is Genetic Technologies Ltd Sponsored ADR.

CEO
Simon Morriss
Employees
—
Headquarters
Fitzroy, Victoria (VIC)
Founded
1987
Market Cap
84.77M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.32M
High Today
$4.56
Low Today
$4.22
Open Price
$4.39
Volume
518.20K
52 Week High
$10.30
52 Week Low
$1.41

You May Also Like

PHI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure